DK0588797T3 - N- 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracen-yl carbonyl aminosyrer nyttige ved behandling af osteoartikulære lidelser - Google Patents

N- 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracen-yl carbonyl aminosyrer nyttige ved behandling af osteoartikulære lidelser

Info

Publication number
DK0588797T3
DK0588797T3 DK92905647.1T DK92905647T DK0588797T3 DK 0588797 T3 DK0588797 T3 DK 0588797T3 DK 92905647 T DK92905647 T DK 92905647T DK 0588797 T3 DK0588797 T3 DK 0588797T3
Authority
DK
Denmark
Prior art keywords
trihydroxy
anthracenyl
dioxo
dihydroxy
dihydro
Prior art date
Application number
DK92905647.1T
Other languages
English (en)
Inventor
Sergio Rosini
Maurizio Mian
Original Assignee
Gentili Ist Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentili Ist Spa filed Critical Gentili Ist Spa
Application granted granted Critical
Publication of DK0588797T3 publication Critical patent/DK0588797T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/24—Anthracenes; Hydrogenated anthracenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK92905647.1T 1991-03-12 1992-03-04 N- 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracen-yl carbonyl aminosyrer nyttige ved behandling af osteoartikulære lidelser DK0588797T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910658A IT1244773B (it) 1991-03-12 1991-03-12 N-(4,5-diidrossi-e 4,5,8-triidrossi-9,10-diidro-9,10-diosso-2- antracen-il)carbonil) amminoacidi utilizzabili nella terapia delle affezioni osteoarticolari

Publications (1)

Publication Number Publication Date
DK0588797T3 true DK0588797T3 (da) 1996-06-17

Family

ID=11359001

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92905647.1T DK0588797T3 (da) 1991-03-12 1992-03-04 N- 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracen-yl carbonyl aminosyrer nyttige ved behandling af osteoartikulære lidelser

Country Status (21)

Country Link
US (1) US5451606A (da)
EP (1) EP0588797B1 (da)
JP (1) JP2979054B2 (da)
KR (1) KR100224330B1 (da)
AT (1) ATE134363T1 (da)
AU (1) AU661475B2 (da)
CA (1) CA2105683C (da)
CZ (1) CZ282997B6 (da)
DE (1) DE69208464T2 (da)
DK (1) DK0588797T3 (da)
ES (1) ES2084348T3 (da)
FI (1) FI113167B (da)
GR (1) GR3019069T3 (da)
HU (1) HU215436B (da)
IT (1) IT1244773B (da)
MX (1) MX9201055A (da)
NO (1) NO304592B1 (da)
PT (1) PT100216B (da)
RU (1) RU2111959C1 (da)
SK (1) SK280134B6 (da)
WO (1) WO1992016496A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ245989A (en) * 1992-02-28 1995-02-24 Lilly Industries Ltd Anthraquinone derivatives and pharmaceutical compositions
GB9417102D0 (en) * 1994-08-24 1994-10-12 Lilly Industries Ltd Pharmaceutical compounds
IT1276781B1 (it) * 1995-06-23 1997-11-03 Gentili Ist Spa Derivati antrachinonmono- e disolfon- sostituiti e composizioni farmaceutiche che li contengono per il trattamento delle patologie
GB2398780A (en) * 2003-02-26 2004-09-01 Arakis Ltd 1,8-dihydroxyanthraquinone-6-carboxamide derivatives as inhibitors of T-cell proliferation for treatment of autoimmune or inflammatory conditions
CN102060809B (zh) * 2009-05-01 2015-05-20 常州高新技术产业开发区三维工业技术研究所有限公司 一种大黄酸衍生物及其制备和用途
CN102225913B (zh) * 2011-04-07 2013-09-04 栗进才 大黄酸衍生物以及它们的治疗用途
RU2466134C1 (ru) * 2011-06-24 2012-11-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Иркутский государственный университет" Способ получения катионных комплексов палладия
CN104557603A (zh) * 2014-12-08 2015-04-29 石河子大学 一种大黄酸类化合物及制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA761627B (en) * 1976-03-16 1978-01-25 C Friedmann Improvements in or relating to the treatment of arthritis
US4966918A (en) * 1989-01-27 1990-10-30 Sloan-Kettering Institute For Cancer Research Derivatives of chryosphanol

Also Published As

Publication number Publication date
ES2084348T3 (es) 1996-05-01
DE69208464T2 (de) 1996-07-11
CA2105683A1 (en) 1992-09-13
PT100216A (pt) 1993-05-31
KR100224330B1 (ko) 1999-10-15
PT100216B (pt) 1999-06-30
CA2105683C (en) 2003-09-16
HU9302510D0 (en) 1993-12-28
GR3019069T3 (en) 1996-05-31
NO933241L (no) 1993-09-10
HUT65218A (en) 1994-05-02
CZ282997B6 (cs) 1997-12-17
CZ182993A3 (en) 1994-07-13
NO933241D0 (no) 1993-09-10
EP0588797B1 (en) 1996-02-21
RU2111959C1 (ru) 1998-05-27
FI933925A (fi) 1993-09-08
JPH10502050A (ja) 1998-02-24
AU1359692A (en) 1992-10-21
IT1244773B (it) 1994-08-08
ATE134363T1 (de) 1996-03-15
SK280134B6 (sk) 1999-08-06
ITMI910658A0 (it) 1991-03-12
JP2979054B2 (ja) 1999-11-15
FI113167B (fi) 2004-03-15
FI933925A0 (fi) 1993-09-08
AU661475B2 (en) 1995-07-27
NO304592B1 (no) 1999-01-18
SK94793A3 (en) 1994-03-09
HU215436B (hu) 1999-09-28
ITMI910658A1 (it) 1992-09-12
MX9201055A (es) 1992-09-01
EP0588797A1 (en) 1994-03-30
DE69208464D1 (en) 1996-03-28
US5451606A (en) 1995-09-19
WO1992016496A1 (en) 1992-10-01

Similar Documents

Publication Publication Date Title
DK0775129T3 (da) 3-Benzoylbenzofuranderivater som thyroidhormonantagonister
LU91145I2 (fr) FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX).
DZ1794A1 (fr) Nouvelle formule pharmaceutique.
BR1100412A (pt) Composto; método para propiciar tratamento imunomodulador; e composição farmacêutica para tratamento imunomodulador
GR3033528T3 (en) Novel piperidine derivatives with paf antagonist activity
DK0588797T3 (da) N- 4,5-dihydroxy- og 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracen-yl carbonyl aminosyrer nyttige ved behandling af osteoartikulære lidelser
ATE181333T1 (de) Azirdin-derivate, deren herstellung und verwendung
ES2108595A1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
HUT50325A (en) Process for producing bisphenylalkyl piperazine derivatives and pharmaceutical compositions comprising same as active ingredient
ATE223915T1 (de) Neue heterozyklische chemie
DE69315836D1 (de) Pyrazolpyridine für die behandlung der anämie
ES2104509A1 (es) Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.
MX9205365A (es) Imidazolilmetil-piridinas y composicion farmaceutica que las contiene.
ATE104313T1 (de) Neue 9-g(a)-hydroxy-3-oxo-4,24(25)-stigmastadien26-s|urederivate,verfahren zur herstellung und heilmittel daraus.
ATE166339T1 (de) Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-deriv te
IL99777A0 (en) Indole derivatives,processes for their preparation and pharmaceutical compositions containing them
ZA916977B (en) Pharmaceutical compositions for use in treating aids
IL117083A (en) Pyridine and pyridazine derivatives processes for the production thereof and pharmaceutical compositions containing these compounds
GR3035010T3 (en) New derivatives of glycylanilides, preparation and therapeutical application